{"count": 1, "results": [{"_id": "18266852", "pmid": 18266852, "title": "Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.", "journal": "Int J Clin Pract", "authors": ["Reckless JP", "Henry P", "Pomykaj T", "Lim ST", "Massaad R", "Vandormael K", "Johnson-Levonas AO", "Lis K", "Brudi P", "Allen C"], "date": "2008-04-01T00:00:00Z", "doi": "10.1111/j.1742-1241.2008.01697.x", "meta_date_publication": "2008 Apr", "meta_volume": "62", "meta_issue": "4", "meta_pages": "539-54", "score": 50074.055, "text_hl": "CONCLUSIONS: In @SPECIES_9606 @@@patients@@@ taking a statin and admitted to the hospital for investigation of a @<m>DISEASE_Coronary_Aneurysm</m> @DISEASE_MESH:D003323 @@@coronary event@@@, treatment with @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@Eze/Simva@@@ 10/40 mg for 12 weeks produced greater improvements in @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipids@@@ with a similar safety profile compared with doubling of the statin dose.", "citations": {"NLM": "Reckless JP, Henry P, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO, Lis K, Brudi P, Allen C. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study. Int J Clin Pract. 2008 Apr;62(4):539-54. PMID: 18266852", "BibTeX": "@article{18266852, title={Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.}, author={Reckless JP and Henry P and Pomykaj T and Lim ST and Massaad R and Vandormael K and Johnson-Levonas AO and Lis K and Brudi P and Allen C}, journal={Int J Clin Pract}, volume={62}, number={4}, pages={539-54}}"}}]}